Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leora R Feldstein

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
MMWR. Morbidity and Mortality Weekly Report|December 8, 2022
Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022Amanda B Payne, Logan C Ray, Matthew M Cole, et al.
Journal of the Pediatric Infectious Diseases Society|February 29, 2020
Vaccine Effectiveness Against Influenza Hospitalization Among Children in the United States, 2015-2016Leora R Feldstein, Constance Ogokeh, Brian Rha, et al.
MMWR. Morbidity and Mortality Weekly Report|September 11, 2020
Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities - United States, July 2020Kiva A Fisher, Mark W Tenforde, Leora R Feldstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2020
Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND)Leora R Feldstein, Wesley H Self, Jill M Ferdinands, et al.
The Journal of Infectious Diseases|November 27, 2020
Investigation of a Large Diphtheria Outbreak and Cocirculation of Corynebacterium pseudodiphtheriticum Among Forcibly Displaced Myanmar Nationals, 2017-2019Lauren M Weil, Margaret M Williams, Tahmina Shirin, et al.
The Journal of Infectious Diseases|May 20, 2021
Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness EstimatesLeora R Feldstein, Jill M Ferdinands, Wesley H Self, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2021
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative StudyCarlos G Grijalva, Leora R Feldstein, H Keipp Talbot, et al.
Vaccine|August 11, 2021
Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020Kelsey L Lytle, Sean P Collins, Leora R Feldstein, et al.
JAMA Network Open|February 24, 2025
COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 YearsAnna R Yousaf, Josephine Mak, Lisa Gwynn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2022
Vaccine Effectiveness Against Life-Threatening Influenza Illness in US ChildrenSamantha M Olson, Margaret M Newhams, Natasha B Halasa, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
MMWR. Morbidity and Mortality Weekly Report|December 8, 2022
Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022Amanda B Payne, Logan C Ray, Matthew M Cole, et al.
Journal of the Pediatric Infectious Diseases Society|February 29, 2020
Vaccine Effectiveness Against Influenza Hospitalization Among Children in the United States, 2015-2016Leora R Feldstein, Constance Ogokeh, Brian Rha, et al.
MMWR. Morbidity and Mortality Weekly Report|September 11, 2020
Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities - United States, July 2020Kiva A Fisher, Mark W Tenforde, Leora R Feldstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2020
Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND)Leora R Feldstein, Wesley H Self, Jill M Ferdinands, et al.
The Journal of Infectious Diseases|November 27, 2020
Investigation of a Large Diphtheria Outbreak and Cocirculation of Corynebacterium pseudodiphtheriticum Among Forcibly Displaced Myanmar Nationals, 2017-2019Lauren M Weil, Margaret M Williams, Tahmina Shirin, et al.
The Journal of Infectious Diseases|May 20, 2021
Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness EstimatesLeora R Feldstein, Jill M Ferdinands, Wesley H Self, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2021
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative StudyCarlos G Grijalva, Leora R Feldstein, H Keipp Talbot, et al.
Vaccine|August 11, 2021
Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020Kelsey L Lytle, Sean P Collins, Leora R Feldstein, et al.
JAMA Network Open|February 24, 2025
COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 YearsAnna R Yousaf, Josephine Mak, Lisa Gwynn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2022
Vaccine Effectiveness Against Life-Threatening Influenza Illness in US ChildrenSamantha M Olson, Margaret M Newhams, Natasha B Halasa, et al.
Pageof 9